FDgard®
FDgard®, licence 80111749: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- IBgard FD, Intestinal Bowel GARD FD, Intestinal Bowel GARD Functional Dyspepsia
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80111749
- Status
- Active licence
- Licence date
- 30 July 2021
- Revision date
- 16 August 2024
- Form
- Capsule, libération-retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Rouge FD&C No. 3, Poly(sorbate) 80, Copolymère d'acide méthacrylique, Monostéarate de glycéryle, Gélatine, Croscarmellose de sodium, Hypromellose, Méthylcellulose, Citrate de triéthyle, Cellulose microcristalline, Bleu FD&C n° 1
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Supportive/adjunct therapy to temporarily help relieve symptoms (including sensations of pressure, heaviness, and fullness) associated with functional dyspepsia (such as recurrent indigestion/persistent indigestion) in 24 hours
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use.
- Contre-indications
Do not use if you are allergic to plants of the Apiaceae/Carrot family.
Source
Official Health Canada record, licence 80111749
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.